FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAugust 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
WEBI am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on …
News Details - Moderna
WEBMar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
WEBSep 11, 2023 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Moderna Advances Multiple Vaccine Programs to Late-Stage …
WEBMar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.
Moderna, Pfizer say updated Covid vaccines were effective …
WEBSep 6, 2023 · New Covid vaccines from Moderna and Pfizer produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, the companies said ...
Moderna's updated COVID-19 vaccine for 2024-25 approved in …
WEBSep 17, 2024 · Vaccine targets KP.2 variant, one of the latest offshoots of Omicron. Health Canada has authorized Moderna's updated COVID-19 vaccine, shown here in August 2024. (Moderna/The Canadian Press ...
FDA Approves Updated COVID-19 Vaccine for 2024-2025 Season
WEB1 day ago · Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines; if ...
Moderna Announces First Participant Dosed in Pivotal Phase 3 …
WEB1 day ago · CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403.Global recruitment for the Nova 301 trial has also begun.
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
WEBAug 22, 2024 · Pfizer, Moderna and Novavax are charging up to $150 per dose for a Covid vaccine, according to data from the Centers for Medicare and Medicaid Services.